| GlaxoSmithKline AG - Zejula 100 mg, Kapseln |
| 66763 | | 01 | | Zejula 100 mg | | Kapseln | | L01XK02 | | Niraparib | | 03.10.2018 | | |
|
| Composition |
| Kapsel: niraparibum 100 mg ut niraparibi tosilas monohydricus, color.: E 133, E 127, E 102, excipiens pro capsula. |
| Packungsbestandteile |
| Capsules | | | | | | | | Principe actif | Concentr. | informations additionels |
|---|
| Niraparibum | 100 mg | Kapsel |
| | BAG: Principe actif | Concentr. |
|---|
| Niraparibum | 100 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| E 102 | | color. | | E 127 | | color. | | E 133 | | color. |
| |
|
|
